Fibronostics
In vitro diagnostics platform for metabolic conditions detection and prognosis, powered by artificial intelligence.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD49—74m (Dealroom.co estimates Aug 2020.)
Orlando Florida (HQ)
Authorizing premium user...